Physician profile
Anna Aronzon
NPI 1245279488
$1,645.31
in general payments reported to CMS, 2019-2025
17 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $333 · 2021: $100 · 2022: $266 · 2023: $172 · 2024: $227 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $304.03 | 2019-2025 | |
| Alk-Abello, INC | $213.02 | 2019-2024 | Ragwitek, Odactra, Grastek |
| Kaleo, INC. | $202.62 | 2019-2024 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $169.84 | 2019-2020 | |
| Genzyme Corporation | $145.11 | 2020-2025 | |
| Glaxosmithkline, LLC. | $130.52 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $82.02 | 2024-2025 | Voquezna |
| Integra Lifesciences Corporation | $81.30 | 2022 | |
| Blueprint Medicines Corporation | $76.63 | 2023-2024 | Ayvakit |
| Takeda Pharmaceuticals U.S.A., INC. | $59.07 | 2024-2025 | Cuvitru |
| Novartis Pharmaceuticals Corporation | $44.47 | 2019-2025 | |
| Acclarent, INC | $38.40 | 2019 | |
| Shire North American Group INC | $24.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.83 | 2020 | |
| Circassia INC. | $17.22 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $16.88 | 2025 | Anzupgo |
| Amgen INC. | $16.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Aronzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.